These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10091198)

  • 21. Gonadal hormone substitutes: effects on the cardiovascular system.
    Clarkson TB; Cline JM; Williams JK; Anthony MS
    Osteoporos Int; 1997; 7 Suppl 1():S43-51. PubMed ID: 9205646
    [No Abstract]   [Full Text] [Related]  

  • 22. Hormone replacement therapy in clinical cardiology.
    Bittner V
    Cardiol Rev; 2000; 8(1):57-64. PubMed ID: 11174874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raloxifene.
    Balfour JA; Goa KL
    Drugs Aging; 1998 Apr; 12(4):335-41; discussion 342. PubMed ID: 9571395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?
    Wells G; Herrington DM
    Drugs Aging; 1999 Dec; 15(6):419-22. PubMed ID: 10641952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.
    Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; Anderson PW
    J Womens Health; 1998 Sep; 7(7):839-47. PubMed ID: 9785310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designer estrogens.
    Jordan VC
    Sci Am; 1998 Oct; 279(4):60-7. PubMed ID: 9768522
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 28. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
    Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of raloxifene hydrochloride on the endometrium of postmenopausal women.
    Boss SM; Huster WJ; Neild JA; Glant MD; Eisenhut CC; Draper MW
    Am J Obstet Gynecol; 1997 Dec; 177(6):1458-64. PubMed ID: 9423751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.
    Anderson TJ
    Am J Cardiol; 1998 Jul; 82(2):236-9. PubMed ID: 9678297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [WHI study on the attention of menopause in Spain: significance of its results].
    Palacios S; Calaf J; Cano A; Parrilla JJ;
    Med Clin (Barc); 2003 Feb; 120(4):146-7. PubMed ID: 12605841
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone replacement therapy should be administered as secondary prevention of coronary artery disease.
    Spencer AP
    Pharmacotherapy; 2000 Sep; 20(9):1028-33. PubMed ID: 10999493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).
    Bushnell CD; Newby LK; Goldstein LB; Lin F; Yaffe K; Simon JA
    Neurology; 2004 Mar; 62(6):968-70. PubMed ID: 15037702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
    Randolph JF;
    Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
    Schneider LS
    JAMA; 2004 Jun; 291(24):3005-7. PubMed ID: 15213214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.